Inactive Instrument

All News Prometheus Biosciences, Inc.

Equities

RXDX

US74349U1088

All News

Unlock all the news: Be the first to know and act before the market!

S&P 500 Posts Weekly Decline Led by Real Estate, Energy as Fed Officials Point to More Rate Increases	23-06-23	MT
Prometheus Biosciences, Inc.(NasdaqGS:RXDX) dropped from S&P Global BMI Index	23-06-21	CI
Prometheus Biosciences, Inc.(NasdaqGS:RXDX) dropped from S&P TMI Index	23-06-21	CI
Prometheus Biosciences, Inc.(NasdaqGS:RXDX) dropped from S&P Biotechnology Select Industry Index	23-06-21	CI
Global markets live: Adobe, Eli Lilly, Nasdaq, Intel, UBS...	23-06-20
Merck Completes Acquisition of Prometheus Biosciences, Inc.	23-06-19	AQ
Paris-listed Drugmaker Merck & Co. Buys Prometheus Biosciences	23-06-19	MT
Prometheus Biosciences, Inc.(NasdaqGM:) dropped from NASDAQ Composite Index	23-06-19	CI
Prometheus Biosciences, Inc.(NasdaqGS:RXDX) dropped from NASDAQ Biotechnology Index	23-06-19	CI
Merck & Company Completes Acquisition of Prometheus Biosciences for $10.8 Billion in Cash; to Cut EPS Outlook in August	23-06-16	MT
Prometheus Biosciences, Inc. Announces Management Changes	23-06-16	CI
Prometheus Biosciences, Inc. Announces Cessation of Mark C. McKenna as CEO	23-06-16	CI
Prometheus Biosciences, Inc. Announces Cessation of Keith W. Marshall as CFO	23-06-16	CI
Merck & Co., Inc. completed the acquisition of Prometheus Biosciences, Inc. from a group of shareholders.	23-06-15	CI
PROMETHEUS BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	23-06-15	AQ
RXDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Prometheus Biosciences, Inc. Is Fair to Shareholders	23-05-24	BU
PROMETHEUS BIOSCIENCES, INC. : Other Events (form 8-K)	23-05-23	AQ
PROMETHEUS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. - RXDX	23-05-22	BU
Analysis-Amgen's antitrust woes spur wider pharmaceutical deal fears	23-05-17	RE
US FTC sues to block Amgen's $27.8 bln deal for Horizon Therapeutics	23-05-16	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Prometheus Biosciences, Inc.

Equities

RXDX

US74349U1088

All News

Filters